Generate a tailored SOP for Dr. Gincy George. Improve your application with a focused, well-structured draft.
Gincy George is a senior epidemiologist and Real World Evidence Partnerships Lead at King's College London, focusing on transforming cancer outcomes through her expertise in pharmacoepidemiology. She leads international collaborative projects investigating treatment patterns and clinical outcomes in various tumor types, including colorectal cancer, hepatocellular carcinoma, and prostate cancer. Gincy oversees the setup and maintenance of significant registries like the national DPYD registry and a cardio-oncology database, honing in on clinically significant outcomes. Her collaborative work with Professor Ton Coolen’s team involves applying advanced mathematical theories to cancer data, utilizing the Swedish Apolipoprotein-related Mortality Risk (AMORIS) database. Additionally, she supports the European Academy of Allergy and Clinical Immunology's AllergoOncology group, providing expertise in study design and statistical analysis. Gincy's research outputs include peer-reviewed articles on real-world data studies, guidelines variations in cancer treatment, and the impacts of COVID-19 on cancer populations. Engaging actively in academia and healthcare, she continues to contribute to the understanding and improvement of cancer treatment methodologies.
King's College London • London
Leading Real World Evidence Partnerships focusing on cancer outcomes and treatment patterns.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.